[[{“value”:”
European Medicines Agency approval of Dupixent in chronic obstructive pulmonary disease makes the drug the first biologic therapy approved for treating the prevalent respiratory condition. In COPD, Dupixent addresses what’s called type 2 inflammation.
The post Sanofi & Regeneron Drug Dupixent Gets EMA Approval as the First Biologic COPD Med appeared first on MedCity News.
“}]]
